Kesimpta 20 MG/0.4 ML pen 0.4ML
Ended Awarded
- Contract number
- SPE2DB25FAWBS
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,195
Award facts
- Contract value 100% obligated
- $13,195.27 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,195.27 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, on August 20, 2025, with completion scheduled for August 21, 2025. This firm fixed-price delivery order is for KESIMPTA 20 mg/0.4 ml pen (ofatumumab), a prescription medication used to treat relapsing forms of multiple sclerosis. The contract is issued under DMS Pharmaceutical Group's existing $500 million Indefinite Delivery Contract with the Defense Logistics Agency's pharmaceutical supply program (SPE2DB), which enables the agency to procure a comprehensive range of pharmaceutical products to support military healthcare facilities worldwide. No set-aside designation was used for this award, and the point of performance is located in Conshohocken, Pennsylvania.
As an established federal pharmaceutical supplier since 2001, DMS Pharmaceutical Group provides branded and generic prescription drugs, biologics, and medical consumables directly to Department of Defense healthcare sites. The company's robust contract history with the Defense Logistics Agency demonstrates consistent performance in delivering specialized pharmaceutical products across multiple therapeutic categories. This delivery order for KESIMPTA represents routine pharmaceutical procurement supporting military health system operations and continues DMS Pharmaceutical Group's role as a critical supplier within the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FAWBS?
SPE2DB25FAWBS was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 20, 2025.
How much is contract SPE2DB25FAWBS worth?
The government has obligated $13,195 on SPE2DB25FAWBS.
Is contract SPE2DB25FAWBS an order under another contract?
Yes. SPE2DB25FAWBS is a delivery order under SPE2DB24D2106, an indefinite delivery contract.
Was contract SPE2DB25FAWBS competed?
The extent of competition for SPE2DB25FAWBS was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award